ZNF683-positive tissue-resident memory T cells organize treatment-refractory niches with targetable circuits in inclusion body myositis
In the authors' words
Inclusion body myositis (IBM) is a progressive autoimmune myositis refractory to conventional immunosuppression, yet mechanisms sustaining chronic inflammation remain unresolved. Integrating comparative single-nucleus RNA sequencing, spatial transcriptomics, and orthogonal validation across autoimmune myositis, we identified ZNF683+IL7R+ cytotoxic tissue-resident memory T (TRM) cells with natural killer cell-like features enriched in IBM. Trajectory analysis positioned an early-disease ZBTB16+ cytotoxic T cell state upstream of ZNF683+IL7R+TRM. ZNF683 overexpression induced memory and natural killer cell-like transcriptional programs while attenuating glucocorticoid-response signatures, linking this program to treatment refractoriness. Ligand-receptor modeling nominated candidate targetable circuits involving IL-15-IL15RA, XCL1-XCR1, and HMGB1/CXCL12-CXCR4. Spatial transcriptomics localized ZNF683+TRM to stress-associated IBM niches. These findings define a disease-specific TRM-centered circuit linked to treatment refractoriness and candidate therapeutic vulnerabilities in IBM.
Appeared: Wednesday, November 18. medRxiv. Preprint, not yet peer-reviewed.